title: Brain gamma-aminobutyric acid changes in stiff-person syndrome.
abstract: BACKGROUND
  Patients with stiff-person syndrome (SPS) have circulating antibodies against glutamic acid decarboxylase, the rate-limiting enzyme responsible for the synthesis of gamma-aminobutyric acid (GABA). Although the patients' symptoms of stiffness and unexpected spasms can be explained on the basis of reduced or impaired inhibitory neurotransmitters, such as GABA, it is unclear whether the level of GABA in the brains of these patients is reduced and, if so, whether the reduction is due to anti-glutamic acid decarboxylase antibodies.
  
  
  OBJECTIVE
  To measure GABA levels in the brains of patients with SPS.
  
  
  METHODS
  Prospective case-control study.
  
  
  METHODS
  National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.
  
  
  METHODS
  Eight patients with SPS with high titers of circulating anti-glutamic acid decarboxylase antibodies and typical clinical symptoms of SPS and 16 control subjects.
  
  
  METHODS
  Results of brain magnetic resonance imaging and magnetic resonance spectroscopy, which measures GABA levels in specific brain regions.
  
  
  RESULTS
  No abnormalities were noted on brain magnetic resonance images. A prominent and significant decrease in GABA level was, however, observed in the sensorimotor cortex and a smaller decrease in the posterior occipital cortex but not in the cingulate cortex or pons.
  
  
  CONCLUSIONS
  The reduction of brain GABA in patients with SPS supports the clinical symptoms and indicates that the inhibitory GABAergic pathways are involved in the disease. Regardless of the responsible autoantigens, in SPS autoantibodies block the function of GABAergic neurons and interfere with the synthesis of GABA but do not cause structural changes in the brain.
authors.affiliation: Neuroimaging Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. llevy@mfa.gwu.edu
authors.forename: Lucien M
authors.initials: LM
authors.lastname: Levy
authors.forename: Igor
authors.initials: I
authors.lastname: Levy-Reis
authors.forename: Mavis
authors.initials: M
authors.lastname: Fujii
authors.forename: Marinos C
authors.initials: MC
authors.lastname: Dalakas
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011877:Radionuclide Imaging; D016750:Stiff-Person Syndrome / Q000000981:diagnostic imaging / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000032:analysis / Q000378:metabolism*
chemical_list: D005680:gamma-Aminobutyric Acid